Implementing Data Integrity to Improve Outcomes In Biopharmaceutical Manufacturing

As pharmaceutical manufacturing continues to rely more heavily on electronic data, maintaining the integrity of that data is crucial to safeguarding increasingly high-value drug products. Ensuring that the data generated as part of a manufacturing process is handled correctly and safely can mean the difference between regulatory and commercial success and failure. 

James Burback (Director, Project Farma), Jordan Krist (Consultant, Project Farma), and Parla Hoelter (Manager, Project Farma) discuss how establishing a culture of data integrity as early as possible contributes to improved outcomes in biopharmaceutical manufacturing in “Implementing Data Integrity To Improve Outcomes In Biopharmaceutical Manufacturing”. 

To read the article in full, click here! 

Published: August 2022